References
- Child T J, Thomas J, Rees M, MacKenzie I Z. Morbidity of first trimester aspiration termination and the seniority of the surgeon. Hum Reprod 2001; 16: 875–878
- Stubblefield P G, Carr-Ellis S, Borgatta L. Methods for induced abortion. Obstet Gynecol 2004; 104: 174–185
- Grimes D A, Schulz K F, Cates W J. Prevention of uterine perforation during curettage abortion. JAMA 1984; 251: 2108–2111
- Vimala N, Mittal S, Kumar S. Sublingual misoprostol for preabortion cervical ripening in first-trimester pregnancy termination. Contraception 2003; 67: 295–297
- Cakir L, Dilbaz B, Caliskan E, et al. Comparison of oral and vaginal misoprostol for cervical ripening before manual vacuum aspiration of first trimester pregnancy under local anesthesia: A randomized placebo-controlled study. Contraception 2005; 71: 337–342
- Tang O S, Schweer H, Seyberth H W, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002; 17: 332–336
- Ho P C, Ngai S W, Liu K L, et al. Vaginal misoprostol compared with oral misoprostol in termination of second trimester pregnancy. Obstet Gynecol 1997; 90: 735–738
- Zieman M, Fong S K, Benowitz N L, et al. Absorption kinetics of misoprostol with oral and vaginal administration. Obstet Gynecol 1997; 90: 88–92
- Rane S M, Pandis G K, Guirgis R R, et al. Pre-induction sonographic measurement of cervical length in prolonged pregnancy: The effect of parity in the prediction of induction to delivery interval. Ultrasound Obstet Gynecol 2003; 22: 40–44
- Ngai S W, Chan Y M, Tang O S, Ho P C. The use of misoprostol for preoperative cervical dilatation prior to vacuum aspiration: a randomized trial. Hum Reprod 1999; 14: 2139–2142
- World Health Organization. Safe abortion: Technical and policy guidance for health systems. World Health Organization, Geneva 2003
- Cook R J, Dickens B M, Horga M. Ethical and legal issues in reproductive health. Safe abortion: WHO technical and policy guidance. Int J Gynecol Obstet 2004; 86: 79–84
- Ngai S W, Tang O S, Lao T, Ho P C. Oral misoprostol versus placebo for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestation. Contraception 1995; 51: 335–337
- Lawrie A, Penny G, Templeton A AA. Randomized comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy. Br J Obstet Gynaecol 1996; 103: 1117–1119
- Ashok P W, Hamoda H, Nathani F, et al. Randomized controlled study comparing oral and vaginal misoprostol for cervical priming prior to surgical termination of pregnancy. Br J Obstet Gynaecol 2003; 110: 1057–1061
- Kaali S G, Szigetvari I A, Bartfai G S. The frequency and management of uterine perforations during first trimester abortions. Am J Obstet Gynecol 1989; 161: 406–408